Statins showed potential benefits in advanced chronic liver disease, preserving hepatic function and reducing shunting and the development of acute-on-chronic liver failure during two retrospective studies presented at the 2021 Liver Meeting.
Use of statins plus metformin was independently associated with preserved hepatic function and reduced shunting in patients with advanced chronic liver disease in one study, while statins were associated with reduced development of acute-on-chronic liver